Update of the CLRP eye plaque brachytherapy database for photon-emitting sources

Habib Safigholi,Zack Parsons,Stephen G. Deering,Rowan M. Thomson
DOI: https://doi.org/10.1002/mp.14844
2021-02-05
Abstract:Purpose: To update and extend the Carleton Laboratory for Radiotherapy Physics (CLRP) Eye Plaque (EP) dosimetry database for low-energy photon-emitting brachytherapy sources using egs_brachy, an open-source EGSnrc application. The previous database, CLRP_EPv1, contained datasets for the Collaborative Ocular Melanoma Study (COMS) plaques (2008). The new database, CLRP EPv2, consists of newly-calculated 3D dose distributions for 17 plaques [8 COMS, 5 Eckert & Ziegler BEBIG, and 4 other representative models] for Pd-103, I-125, and Cs-131 seeds. Methods: Plaque models are developed with egs_brachy, based on published/manufacturer dimensions and material data. The BEBIG plaques are identical in dimensions to COMS plaques but differ in elemental composition and/or density. Eye plaques and seeds are simulated at the centre of full-scatter water phantoms, scoring in (0.05 cm)^3 voxels spanning the eye for scenarios: (i) HOMO: simulated TG43 conditions; (ii) HETERO: eye plaques and seeds fully modelled; (iii) HETsi (BEBIG only): one seed is active at a time with other seed geometries present but not emitting photons (inactive). For validation, doses are compared to those from CLRP_EPv1 and published data. Data Format and Access: Data are available at <a class="link-external link-https" href="https://physics.carleton.ca/" rel="external noopener nofollow">this https URL</a> clrp/eye_plaque_v2, <a class="link-external link-http" href="http://doi.org/10.22215/clrp/EPv2" rel="external noopener nofollow">this http URL</a>. The data consist of 3D dose distributions (text-based EGSnrc 3ddose file) and graphical presentations of the comparisons to previously published data. Potential Applications: The CLRP EPv2 database provides accurate reference 3D dose distributions to advance ocular brachytherapy dose evaluations. The fully-benchmarked eye plaque models will be freely-distributed with egs brachy, supporting adoption of model-based dose evaluations as recommended by TG-129, TG-186, and TG-221.
Medical Physics
What problem does this paper attempt to address?